WOLFGANG WINKELMAYER

Concepts (822)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Renal Dialysis
184
2024
855
26.790
Why?
Kidney Failure, Chronic
167
2024
880
25.980
Why?
Renal Insufficiency, Chronic
93
2025
724
13.090
Why?
Kidney Transplantation
72
2024
647
10.760
Why?
Kidney Diseases
51
2024
480
8.070
Why?
Anemia
37
2023
339
7.570
Why?
Atrial Fibrillation
32
2024
660
6.700
Why?
Hematinics
31
2023
55
6.670
Why?
Nephrology
39
2023
147
6.370
Why?
Peritoneal Dialysis
21
2023
117
5.820
Why?
Medicare
44
2023
428
4.730
Why?
Anticoagulants
22
2024
593
4.520
Why?
Glomerular Filtration Rate
44
2025
507
4.450
Why?
Kidney
44
2023
1368
4.300
Why?
Erythropoietin
21
2023
105
4.150
Why?
Angiotensin-Converting Enzyme Inhibitors
22
2021
225
3.940
Why?
Aged
198
2025
19870
3.820
Why?
Myocardial Infarction
28
2023
1050
3.800
Why?
Hip Fractures
8
2020
61
3.710
Why?
United States
141
2025
10915
3.680
Why?
Warfarin
11
2022
119
3.350
Why?
Humans
441
2025
125189
3.280
Why?
Acute Kidney Injury
21
2022
637
3.220
Why?
Male
264
2025
61525
3.030
Why?
Middle Aged
184
2025
26927
3.020
Why?
Female
273
2025
66806
2.940
Why?
Renal Replacement Therapy
11
2021
142
2.850
Why?
Stroke
22
2022
989
2.790
Why?
Risk Assessment
41
2024
3465
2.670
Why?
Glomerulonephritis
6
2019
73
2.660
Why?
Cardiovascular Diseases
36
2022
1970
2.660
Why?
Hemorrhage
13
2024
470
2.460
Why?
Terminology as Topic
10
2020
223
2.440
Why?
Aged, 80 and over
75
2024
6598
2.380
Why?
Angiotensin Receptor Antagonists
9
2021
128
2.370
Why?
Risk Factors
87
2023
10315
2.300
Why?
Renal Insufficiency
9
2024
239
2.270
Why?
Medicaid
19
2019
243
2.190
Why?
Hypertension
17
2024
1330
2.140
Why?
Incidence
42
2022
3147
2.140
Why?
Cohort Studies
65
2022
4817
2.120
Why?
Iron
14
2023
270
1.960
Why?
Diabetic Nephropathies
9
2019
109
1.910
Why?
Cause of Death
20
2019
476
1.900
Why?
Proportional Hazards Models
34
2021
1360
1.900
Why?
Practice Patterns, Physicians'
15
2021
731
1.890
Why?
Hypoglycemic Agents
10
2022
444
1.810
Why?
Cardiovascular Agents
7
2012
90
1.810
Why?
Prognosis
39
2023
4645
1.760
Why?
Retrospective Studies
87
2024
16353
1.740
Why?
Time Factors
57
2024
6338
1.680
Why?
Adult
101
2024
29628
1.610
Why?
Treatment Outcome
70
2024
12392
1.600
Why?
Ferric Compounds
5
2023
37
1.530
Why?
Blood Pressure
10
2023
1375
1.530
Why?
Delivery of Health Care
5
2020
615
1.500
Why?
Angiotensin II Type 1 Receptor Blockers
10
2010
56
1.500
Why?
Coronary Artery Bypass
9
2016
518
1.460
Why?
Diabetes Mellitus
13
2020
874
1.450
Why?
Hospitalization
25
2021
1783
1.440
Why?
Graft Survival
17
2019
538
1.440
Why?
Antihypertensive Agents
12
2021
414
1.440
Why?
Diabetes Mellitus, Type 2
8
2022
1271
1.440
Why?
Mortality
8
2018
238
1.400
Why?
Prospective Payment System
6
2021
16
1.390
Why?
Fibrinolytic Agents
3
2024
205
1.360
Why?
Follow-Up Studies
41
2022
5176
1.360
Why?
Referral and Consultation
9
2012
543
1.350
Why?
Glycine
7
2022
168
1.350
Why?
Heparin
6
2014
224
1.340
Why?
Altitude
4
2012
23
1.340
Why?
Arteriovenous Shunt, Surgical
7
2024
101
1.320
Why?
Caregivers
7
2022
574
1.320
Why?
Heart Failure
15
2021
2298
1.300
Why?
Homocysteine
7
2005
123
1.270
Why?
Coronary Disease
7
2016
678
1.260
Why?
Survival Rate
27
2022
2062
1.260
Why?
Registries
19
2025
1435
1.250
Why?
Percutaneous Coronary Intervention
6
2017
253
1.230
Why?
Renin-Angiotensin System
5
2021
102
1.210
Why?
Glucaric Acid
4
2023
10
1.210
Why?
Population Surveillance
4
2022
389
1.210
Why?
Hyperkalemia
6
2024
67
1.170
Why?
Comorbidity
21
2020
1534
1.170
Why?
Graft Rejection
12
2024
590
1.160
Why?
Potassium
7
2024
282
1.160
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
11
2020
734
1.150
Why?
Hemoglobins
17
2023
311
1.120
Why?
Gastrointestinal Hemorrhage
3
2014
227
1.080
Why?
Economic Competition
4
2023
14
1.080
Why?
Living Donors
3
2024
111
1.070
Why?
Darbepoetin alfa
10
2023
15
1.060
Why?
Practice Guidelines as Topic
12
2021
1272
1.060
Why?
Thrombosis
3
2024
526
1.060
Why?
Medication Adherence
4
2012
398
1.050
Why?
Coronary Artery Disease
8
2019
814
1.020
Why?
Health Policy
5
2021
213
1.000
Why?
Proton Pump Inhibitors
3
2022
277
0.950
Why?
Factor XI
2
2024
3
0.950
Why?
Drug Prescriptions
10
2024
219
0.940
Why?
Anemia, Iron-Deficiency
6
2023
136
0.930
Why?
Glomerulonephritis, IGA
3
2019
16
0.910
Why?
Hyperphosphatemia
4
2016
16
0.910
Why?
Disease Progression
15
2025
2067
0.910
Why?
Patient Outcome Assessment
4
2020
92
0.910
Why?
Altruism
1
2024
23
0.900
Why?
Kidney Function Tests
10
2022
129
0.900
Why?
National Health Programs
2
2023
19
0.890
Why?
Multivariate Analysis
21
2016
1438
0.880
Why?
Adrenergic beta-Antagonists
9
2018
244
0.860
Why?
Death, Sudden, Cardiac
8
2022
259
0.850
Why?
Dose-Response Relationship, Drug
14
2024
1697
0.850
Why?
Health Services Accessibility
9
2021
606
0.840
Why?
Aftercare
1
2024
149
0.830
Why?
Nephrectomy
1
2024
178
0.830
Why?
Insurance, Health
4
2018
139
0.820
Why?
Folic Acid
6
2005
294
0.820
Why?
Young Adult
33
2020
9053
0.820
Why?
Electronic Health Records
6
2017
722
0.800
Why?
Patients
2
2020
120
0.800
Why?
Health Care Costs
8
2020
372
0.790
Why?
Picolinic Acids
5
2022
10
0.780
Why?
Prolyl-Hydroxylase Inhibitors
4
2023
4
0.770
Why?
Ficus
1
2021
2
0.750
Why?
Coffee
2
2015
24
0.750
Why?
Hypolipidemic Agents
6
2020
182
0.740
Why?
Logistic Models
16
2020
1810
0.740
Why?
Survival Analysis
15
2018
1506
0.740
Why?
Ambulatory Care
7
2021
390
0.740
Why?
Postoperative Complications
9
2020
3073
0.740
Why?
Immunosuppressive Agents
11
2019
651
0.730
Why?
Vitamin B 12
4
2005
59
0.720
Why?
Caffeine
2
2015
71
0.720
Why?
Diabetes Complications
2
2015
203
0.720
Why?
Central Venous Catheters
2
2018
39
0.720
Why?
Decision Making
5
2020
656
0.710
Why?
Patient Discharge
4
2014
495
0.710
Why?
Depression
3
2019
1237
0.710
Why?
Drug Utilization
7
2020
161
0.710
Why?
Stents
3
2017
888
0.710
Why?
Coronavirus Infections
3
2020
359
0.710
Why?
Pneumonia, Viral
3
2020
375
0.700
Why?
Betacoronavirus
3
2020
289
0.700
Why?
Lupus Nephritis
7
2015
44
0.700
Why?
Cross-Sectional Studies
17
2024
3425
0.690
Why?
Isoquinolines
2
2021
40
0.680
Why?
Carbonated Beverages
2
2012
11
0.650
Why?
Drug Utilization Review
4
2007
33
0.650
Why?
Research Design
9
2018
695
0.650
Why?
Thiazolidinediones
3
2010
82
0.650
Why?
Comparative Effectiveness Research
4
2017
68
0.650
Why?
Databases, Factual
13
2020
1179
0.640
Why?
Clinical Trials as Topic
8
2020
1099
0.640
Why?
Reimbursement Mechanisms
5
2023
36
0.640
Why?
Tacrolimus
6
2019
98
0.640
Why?
Dialysis
1
2019
22
0.630
Why?
Pandemics
4
2021
1107
0.630
Why?
Global Health
3
2020
564
0.630
Why?
Secondary Prevention
5
2012
218
0.620
Why?
Algorithms
8
2019
1629
0.620
Why?
Prevalence
17
2022
2458
0.620
Why?
Guideline Adherence
4
2018
378
0.610
Why?
Pyridines
3
2018
230
0.610
Why?
AIDS-Associated Nephropathy
2
2018
76
0.610
Why?
Metoprolol
1
2018
22
0.600
Why?
Analgesics, Opioid
2
2020
404
0.600
Why?
Histamine H2 Antagonists
1
2018
50
0.590
Why?
Medicare Part D
2
2016
17
0.590
Why?
Adolescent
34
2022
19363
0.590
Why?
Randomized Controlled Trials as Topic
10
2022
1117
0.590
Why?
Creatinine
8
2022
391
0.590
Why?
Age Factors
15
2018
2823
0.590
Why?
Evidence-Based Medicine
6
2020
634
0.580
Why?
Employment
2
2018
69
0.580
Why?
Intracranial Hemorrhages
4
2014
76
0.580
Why?
Ferrosoferric Oxide
2
2015
25
0.580
Why?
Intensive Care Units
1
2021
493
0.580
Why?
Polymorphism, Single Nucleotide
5
2016
2637
0.580
Why?
Brain Ischemia
4
2019
265
0.570
Why?
Attitude to Health
3
2019
257
0.570
Why?
Albuminuria
5
2020
103
0.570
Why?
Healthcare Disparities
7
2024
434
0.570
Why?
Ambulatory Care Facilities
7
2021
227
0.570
Why?
Patient Compliance
4
2008
473
0.570
Why?
Hyperparathyroidism
2
2010
24
0.560
Why?
United States Food and Drug Administration
4
2013
150
0.540
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
4
2006
70
0.540
Why?
Congresses as Topic
8
2024
175
0.540
Why?
Erythropoiesis
4
2022
39
0.530
Why?
Quality of Life
12
2023
1934
0.530
Why?
Air Pollution
2
2021
66
0.530
Why?
Program Evaluation
3
2018
443
0.530
Why?
Epoetin Alfa
6
2016
10
0.520
Why?
Nephrologists
4
2021
13
0.520
Why?
Consensus
13
2023
641
0.520
Why?
Hyperhomocysteinemia
4
2006
38
0.510
Why?
Chelating Agents
4
2016
42
0.510
Why?
Cardiac Surgical Procedures
3
2014
1120
0.510
Why?
Models, Biological
1
2021
1460
0.510
Why?
Barbiturates
1
2015
7
0.500
Why?
Acetates
3
2011
74
0.500
Why?
Confidence Intervals
9
2016
286
0.500
Why?
Air Pollutants
2
2021
102
0.500
Why?
Blood Glucose
2
2017
1131
0.500
Why?
Delayed Graft Function
2
2013
3
0.500
Why?
Lupus Erythematosus, Systemic
5
2017
193
0.490
Why?
Health Status
5
2017
377
0.490
Why?
Reimbursement, Incentive
2
2018
48
0.490
Why?
Administration, Oral
6
2021
684
0.490
Why?
Women's Health
6
2021
134
0.490
Why?
Drug-Related Side Effects and Adverse Reactions
2
2017
259
0.490
Why?
Vascular Diseases
2
2018
168
0.480
Why?
Ferredoxin-NADP Reductase
2
2005
10
0.480
Why?
Terminal Care
2
2014
112
0.480
Why?
Bone Density Conservation Agents
2
2017
51
0.480
Why?
Austria
10
2020
19
0.470
Why?
Fenoldopam
1
2014
11
0.470
Why?
Patient Care Bundles
2
2021
22
0.470
Why?
Publishing
3
2020
110
0.470
Why?
Sleep Apnea Syndromes
1
2016
73
0.470
Why?
Focus Groups
6
2022
198
0.470
Why?
Time-to-Treatment
2
2019
188
0.460
Why?
Clonidine
1
2014
36
0.460
Why?
Metformin
2
2021
151
0.460
Why?
Dialysis Solutions
4
2024
10
0.460
Why?
Polymers
1
2015
104
0.460
Why?
Adrenergic alpha-2 Receptor Agonists
1
2014
26
0.460
Why?
Chronic Disease
11
2011
1197
0.450
Why?
Hemodialysis Units, Hospital
4
2020
9
0.450
Why?
Depressive Disorder
1
2017
454
0.450
Why?
Off-Label Use
2
2012
28
0.450
Why?
Phosphates
3
2016
113
0.440
Why?
Plasma Substitutes
2
2003
7
0.440
Why?
Hydroxyethyl Starch Derivatives
2
2003
8
0.430
Why?
Coronary Stenosis
1
2014
78
0.430
Why?
Bone Diseases, Metabolic
1
2014
54
0.430
Why?
Antiretroviral Therapy, Highly Active
1
2015
267
0.430
Why?
Residence Characteristics
4
2013
278
0.430
Why?
Hypotension
3
2020
187
0.430
Why?
Rhabdomyolysis
1
2013
37
0.420
Why?
Cyclosporine
4
2019
147
0.420
Why?
Angioplasty, Balloon, Coronary
1
2014
180
0.420
Why?
C-Reactive Protein
3
2007
432
0.420
Why?
Prospective Studies
20
2025
6153
0.420
Why?
Vasodilator Agents
1
2014
206
0.420
Why?
Pregnancy Complications
2
2015
514
0.420
Why?
Heparin, Low-Molecular-Weight
1
2013
23
0.410
Why?
Thromboembolism
3
2021
89
0.410
Why?
Aspirin
1
2014
221
0.410
Why?
Mycophenolic Acid
3
2017
51
0.410
Why?
Insurance Claim Reporting
2
2012
8
0.410
Why?
Counseling
1
2014
219
0.410
Why?
Case-Control Studies
9
2022
3299
0.410
Why?
Qualitative Research
5
2018
539
0.410
Why?
Drinking Behavior
1
2012
8
0.400
Why?
Polyamines
3
2012
27
0.400
Why?
Particulate Matter
2
2021
70
0.400
Why?
New Jersey
8
2012
23
0.400
Why?
Critical Illness
2
2020
601
0.400
Why?
Postoperative Hemorrhage
2
2003
84
0.400
Why?
Platelet Aggregation Inhibitors
1
2014
270
0.400
Why?
Chlorides
1
2012
107
0.390
Why?
Attitude of Health Personnel
2
2018
667
0.390
Why?
Upper Gastrointestinal Tract
1
2012
9
0.380
Why?
Blood Transfusion
1
2014
313
0.380
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2017
307
0.380
Why?
Fluid Therapy
1
2012
129
0.380
Why?
Pennsylvania
5
2012
52
0.380
Why?
Socioeconomic Factors
7
2019
872
0.380
Why?
Venous Thromboembolism
1
2014
167
0.380
Why?
Intestinal Perforation
1
2012
56
0.380
Why?
Naphthalenes
2
2012
37
0.380
Why?
Longitudinal Studies
7
2020
1324
0.370
Why?
Biomedical Research
6
2018
519
0.370
Why?
Ozone
1
2011
18
0.370
Why?
United States Department of Veterans Affairs
1
2015
670
0.370
Why?
Communication
3
2020
517
0.360
Why?
Peptidyl-Dipeptidase A
1
2011
55
0.360
Why?
Vitamin D
2
2010
161
0.360
Why?
Tissue and Organ Procurement
4
2021
224
0.360
Why?
Kaplan-Meier Estimate
6
2017
1056
0.360
Why?
Health Facility Closure
2
2021
8
0.360
Why?
Chronic Kidney Disease-Mineral and Bone Disorder
1
2010
12
0.350
Why?
Calcium Carbonate
1
2010
10
0.350
Why?
Postmenopause
3
2015
126
0.350
Why?
Prescription Drugs
2
2012
54
0.350
Why?
Obesity
2
2020
2248
0.350
Why?
Textiles
2
2020
10
0.350
Why?
Odds Ratio
8
2021
1259
0.340
Why?
Body Mass Index
5
2020
1565
0.340
Why?
Sex Distribution
6
2018
308
0.340
Why?
Defibrillators, Implantable
2
2018
190
0.340
Why?
Heart-Assist Devices
4
2020
1026
0.340
Why?
Masks
2
2020
38
0.340
Why?
Double-Blind Method
6
2024
1637
0.330
Why?
Catheterization, Central Venous
2
2011
131
0.330
Why?
Feeding Behavior
1
2015
702
0.330
Why?
Transplant Recipients
5
2024
219
0.330
Why?
Tissue Plasminogen Activator
1
2011
119
0.330
Why?
Health Services for the Aged
1
2010
38
0.330
Why?
Insurance, Health, Reimbursement
1
2010
34
0.330
Why?
Health Knowledge, Attitudes, Practice
4
2020
854
0.320
Why?
Endpoint Determination
4
2018
56
0.320
Why?
Recombinant Proteins
7
2015
1399
0.320
Why?
Sevelamer
4
2016
10
0.320
Why?
Drug Hypersensitivity
1
2010
95
0.320
Why?
Anaphylaxis
1
2010
81
0.320
Why?
Cyclooxygenase 2 Inhibitors
1
2008
57
0.300
Why?
Blood Coagulation
2
2024
125
0.300
Why?
Administration, Intravenous
4
2017
143
0.300
Why?
Severity of Illness Index
9
2025
2913
0.300
Why?
Models, Statistical
9
2015
471
0.300
Why?
Phosphorus
2
2011
56
0.290
Why?
Cost-Benefit Analysis
7
2013
510
0.290
Why?
International Classification of Diseases
2
2006
90
0.290
Why?
Venous Thrombosis
2
2013
183
0.290
Why?
Drugs, Generic
2
2020
13
0.290
Why?
Drug Administration Schedule
6
2014
729
0.290
Why?
Pulmonary Embolism
2
2013
178
0.280
Why?
Health Care Sector
2
2018
19
0.280
Why?
Myocardial Revascularization
1
2008
103
0.280
Why?
Hyperlipidemias
3
2020
178
0.280
Why?
Hemodialysis, Home
4
2023
12
0.280
Why?
Patient Participation
3
2020
220
0.280
Why?
Predictive Value of Tests
7
2021
2174
0.280
Why?
Blood Vessel Prosthesis Implantation
2
2015
805
0.280
Why?
Hospital Mortality
5
2019
1025
0.270
Why?
Benzodiazepines
1
2007
101
0.270
Why?
Length of Stay
4
2008
1310
0.270
Why?
Peripheral Arterial Disease
2
2021
292
0.270
Why?
Anti-Anxiety Agents
1
2007
74
0.270
Why?
Hemodialysis Solutions
3
2024
5
0.270
Why?
Patient Readmission
4
2020
385
0.270
Why?
Propensity Score
7
2021
216
0.260
Why?
Fee-for-Service Plans
2
2016
18
0.260
Why?
Losartan
1
2006
36
0.260
Why?
Diagnosis-Related Groups
2
2006
28
0.260
Why?
Patient Satisfaction
2
2021
475
0.260
Why?
Hematocrit
4
2011
111
0.260
Why?
Causality
2
2017
84
0.260
Why?
Intraoperative Care
2
2003
105
0.260
Why?
Calcium
3
2011
1102
0.260
Why?
Patient Care Planning
3
2019
122
0.250
Why?
Drug-Eluting Stents
2
2017
64
0.250
Why?
Patient Preference
5
2019
118
0.250
Why?
Quality-Adjusted Life Years
5
2011
112
0.250
Why?
Waiting Lists
4
2024
228
0.250
Why?
Biomarkers
9
2024
3091
0.250
Why?
Citalopram
2
2022
30
0.240
Why?
Outpatients
2
2019
256
0.240
Why?
Health Expenditures
3
2022
103
0.240
Why?
Consensus Development Conferences as Topic
6
2020
39
0.240
Why?
Sertraline
2
2022
44
0.240
Why?
Anemia, Hypochromic
1
2004
7
0.240
Why?
Catheters, Indwelling
1
2006
154
0.240
Why?
Regression Analysis
5
2015
781
0.240
Why?
Risk
5
2013
756
0.230
Why?
Silicates
1
2024
10
0.230
Why?
5,10-Methylenetetrahydrofolate Reductase (FADH2)
1
2004
4
0.230
Why?
Erythrocytes
2
2005
219
0.230
Why?
Health Resources
2
2017
116
0.230
Why?
Statistics as Topic
2
2015
256
0.230
Why?
Data Mining
2
2016
53
0.230
Why?
Torsades de Pointes
2
2024
6
0.230
Why?
Forearm
1
2024
45
0.230
Why?
Coronary Angiography
1
2007
450
0.230
Why?
Transcobalamins
1
2004
4
0.230
Why?
Fluoroquinolones
2
2022
93
0.230
Why?
Vascular Access Devices
2
2014
35
0.230
Why?
Artificial Intelligence
3
2023
242
0.230
Why?
Therapeutics
1
2004
7
0.230
Why?
Chi-Square Distribution
6
2013
589
0.230
Why?
Blood Pressure Determination
3
2020
110
0.230
Why?
Health Surveys
2
2021
244
0.220
Why?
Complement Activation
1
2024
52
0.220
Why?
Morbidity
3
2020
249
0.220
Why?
Vocabulary, Controlled
2
2020
13
0.220
Why?
Surveys and Questionnaires
6
2020
3729
0.220
Why?
Delphi Technique
4
2020
209
0.220
Why?
Oligonucleotides
1
2024
90
0.220
Why?
Transplantation, Homologous
6
2023
667
0.220
Why?
Glutamate Carboxypeptidase II
1
2003
6
0.210
Why?
Analysis of Variance
5
2012
1020
0.210
Why?
Cross-Over Studies
1
2024
315
0.210
Why?
Physicians
2
2014
587
0.210
Why?
Comprehension
2
2020
75
0.210
Why?
Antigens, Surface
1
2003
117
0.200
Why?
Germany
1
2022
65
0.200
Why?
Time
2
2016
92
0.200
Why?
Genotype
6
2019
2565
0.200
Why?
Embolism
1
2022
48
0.200
Why?
Hypokalemia
2
2019
42
0.200
Why?
Nephrosis, Lipoid
2
2019
11
0.190
Why?
Diuretics
2
2021
171
0.190
Why?
Health Facility Merger
2
2019
8
0.190
Why?
Hypertension, Pulmonary
2
2021
440
0.190
Why?
Azithromycin
1
2022
43
0.190
Why?
Ferritins
5
2023
98
0.190
Why?
Membrane Transport Proteins
1
2003
175
0.190
Why?
Nutrition Surveys
2
2021
293
0.190
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2022
24
0.190
Why?
Preventive Health Services
1
2002
61
0.190
Why?
Patient Safety
4
2015
401
0.190
Why?
Calcium Compounds
3
2011
7
0.190
Why?
Arthritis, Rheumatoid
1
2025
261
0.190
Why?
Diagnostic Tests, Routine
1
2002
117
0.180
Why?
Prosthesis Implantation
2
2020
141
0.180
Why?
Respiratory Tract Diseases
1
2022
75
0.180
Why?
Annual Reports as Topic
1
2021
2
0.180
Why?
Symporters
1
2022
69
0.180
Why?
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
1
2021
8
0.180
Why?
Age Distribution
3
2015
419
0.180
Why?
Mathematical Concepts
1
2021
7
0.180
Why?
Genetic Testing
2
2019
1004
0.180
Why?
Cost of Illness
3
2019
252
0.180
Why?
Uremia
1
2001
35
0.180
Why?
Polymorphism, Genetic
2
2006
816
0.180
Why?
Australia
5
2020
137
0.180
Why?
Poverty
2
2014
425
0.180
Why?
Transferrin
4
2013
50
0.180
Why?
Glucagon-Like Peptide-1 Receptor
1
2021
62
0.180
Why?
Neoplasms
5
2020
2790
0.180
Why?
Arrhythmias, Cardiac
3
2024
460
0.170
Why?
Frustration
1
2020
9
0.170
Why?
Drug Costs
4
2015
61
0.170
Why?
Hospitals, Veterans
2
2021
359
0.170
Why?
Inpatients
2
2019
499
0.170
Why?
Saphenous Vein
2
2013
60
0.170
Why?
Vitamin K
1
2020
37
0.170
Why?
Minority Groups
2
2013
249
0.170
Why?
Polypharmacy
1
2020
40
0.170
Why?
Antibodies, Monoclonal, Humanized
1
2024
511
0.160
Why?
Monitoring, Physiologic
2
2012
377
0.160
Why?
Optic Nerve Diseases
1
2001
88
0.160
Why?
Mitral Valve Stenosis
1
2019
35
0.160
Why?
Education
1
2020
109
0.160
Why?
Patient Care Team
2
2017
542
0.160
Why?
Students, Medical
1
2004
359
0.160
Why?
United Kingdom
2
2020
190
0.160
Why?
Safety-net Providers
1
2019
52
0.160
Why?
Glomerulonephritis, Membranous
1
2019
12
0.160
Why?
Patient Selection
3
2011
699
0.160
Why?
Fear
1
2020
199
0.150
Why?
Sex Characteristics
1
2020
313
0.150
Why?
Self-Management
1
2020
99
0.150
Why?
Biometry
2
2017
136
0.150
Why?
Health Personnel
2
2020
507
0.150
Why?
Dabigatran
1
2018
27
0.150
Why?
Perioperative Care
1
2021
195
0.150
Why?
Interviews as Topic
2
2017
371
0.150
Why?
Health Status Disparities
1
2021
228
0.150
Why?
Mesenteric Ischemia
1
2018
30
0.150
Why?
Sex Factors
6
2015
1289
0.150
Why?
Brain Death
1
2019
61
0.150
Why?
Death
1
2019
71
0.150
Why?
Endocarditis
1
2019
106
0.150
Why?
Rivaroxaban
1
2018
55
0.150
Why?
Calcinosis
1
2019
179
0.150
Why?
Thiazoles
1
2018
98
0.150
Why?
Public Health
3
2016
266
0.150
Why?
Office Visits
2
2017
77
0.150
Why?
Medically Uninsured
2
2019
73
0.150
Why?
Injections, Intravenous
3
2014
249
0.150
Why?
Policy Making
1
2018
59
0.150
Why?
Unemployment
1
2018
20
0.150
Why?
Commerce
1
2018
50
0.150
Why?
Heart Arrest
1
2022
355
0.150
Why?
Carrier Proteins
1
2003
1022
0.140
Why?
Cost Savings
2
2015
71
0.140
Why?
Skilled Nursing Facilities
1
2017
5
0.140
Why?
Pyridones
1
2018
119
0.140
Why?
Costs and Cost Analysis
4
2015
162
0.140
Why?
Periodicals as Topic
1
2020
197
0.140
Why?
Mitral Valve Insufficiency
1
2019
163
0.140
Why?
Tissue Donors
4
2019
494
0.140
Why?
Self Medication
1
2017
23
0.140
Why?
Anuria
1
2017
13
0.140
Why?
Hematologic Neoplasms
1
2020
285
0.140
Why?
Parathyroid Hormone
2
2011
71
0.140
Why?
Family Health
2
2019
259
0.140
Why?
Program Development
1
2018
185
0.140
Why?
Acute Disease
3
2021
1111
0.140
Why?
Azathioprine
1
2017
54
0.140
Why?
Aortic Aneurysm, Abdominal
1
2022
450
0.140
Why?
Veterans Health
1
2018
176
0.140
Why?
Pravastatin
2
2007
22
0.130
Why?
HIV
1
2018
180
0.130
Why?
Treatment Failure
2
2012
341
0.130
Why?
Ischemic Attack, Transient
1
2016
58
0.130
Why?
Emergency Medical Services
1
2001
397
0.130
Why?
Metals
1
2017
63
0.130
Why?
Insurance Coverage
1
2017
122
0.130
Why?
Quality Assurance, Health Care
1
2018
208
0.130
Why?
Health Care Rationing
2
2021
58
0.130
Why?
Thoracic Surgical Procedures
1
2018
102
0.130
Why?
Cholesterol, HDL
1
2018
358
0.130
Why?
Aortic Valve
1
2019
442
0.130
Why?
Kidney Neoplasms
1
2020
438
0.130
Why?
Societies, Medical
3
2020
697
0.130
Why?
Financing, Government
1
2016
30
0.130
Why?
Glycemic Index
1
2015
19
0.130
Why?
Pyrazoles
1
2018
305
0.130
Why?
Computer Simulation
3
2017
652
0.130
Why?
Drinking
1
2015
34
0.130
Why?
Meta-Analysis as Topic
2
2014
160
0.120
Why?
Poisson Distribution
2
2015
50
0.120
Why?
Physician-Patient Relations
2
2017
429
0.120
Why?
Membrane Proteins
1
2003
1527
0.120
Why?
BK Virus
1
2016
60
0.120
Why?
Rare Diseases
1
2017
190
0.120
Why?
Inappropriate Prescribing
1
2015
41
0.120
Why?
Drug Therapy, Combination
4
2016
1172
0.120
Why?
Aortic Valve Stenosis
1
2019
336
0.120
Why?
Parents
2
2022
1024
0.120
Why?
Alleles
3
2005
1614
0.120
Why?
Polyomavirus Infections
1
2016
90
0.120
Why?
Menopause
1
2015
77
0.120
Why?
Tumor Virus Infections
1
2016
135
0.120
Why?
Communicable Diseases
1
2017
161
0.120
Why?
Hematologic Diseases
1
2016
79
0.120
Why?
Central Nervous System Stimulants
1
2015
127
0.120
Why?
International Cooperation
2
2017
156
0.120
Why?
Immune Tolerance
1
2015
144
0.120
Why?
Half-Life
1
2015
158
0.120
Why?
Coronary Restenosis
1
2014
23
0.120
Why?
Canada
4
2019
288
0.120
Why?
Cyclophosphamide
1
2017
417
0.120
Why?
Obesity, Abdominal
1
2014
38
0.120
Why?
Contraindications
1
2014
78
0.120
Why?
Insurance Claim Review
2
2014
27
0.110
Why?
Hemoglobin A
1
2014
22
0.110
Why?
Digoxin
1
2014
43
0.110
Why?
Tissue Banks
1
2014
27
0.110
Why?
Endovascular Procedures
1
2022
737
0.110
Why?
Linear Models
4
2015
683
0.110
Why?
Catheter Ablation
1
2016
233
0.110
Why?
Hemoglobinometry
1
2013
4
0.110
Why?
Drug Approval
2
2012
43
0.110
Why?
Capitation Fee
1
2013
3
0.110
Why?
Internal Mammary-Coronary Artery Anastomosis
1
2013
15
0.110
Why?
Cardiology
1
2019
507
0.110
Why?
Haplotypes
1
2015
522
0.110
Why?
Ownership
3
2019
33
0.110
Why?
Urological Agents
1
2013
4
0.110
Why?
Product Surveillance, Postmarketing
1
2013
31
0.110
Why?
United Nations
1
2013
12
0.110
Why?
Public-Private Sector Partnerships
1
2013
19
0.110
Why?
Transplantation
1
2013
27
0.100
Why?
Adiposity
1
2014
190
0.100
Why?
Allografts
2
2024
191
0.100
Why?
Heart Diseases
2
2015
495
0.100
Why?
Prosthesis-Related Infections
2
2015
179
0.100
Why?
Catheterization
1
2014
235
0.100
Why?
Observation
1
2012
42
0.100
Why?
Health Care Reform
3
2020
51
0.100
Why?
Gene Frequency
2
2004
724
0.100
Why?
Motivation
1
2014
319
0.100
Why?
Influenza, Human
1
2019
662
0.100
Why?
Internal Medicine
2
2011
150
0.100
Why?
Infusions, Intravenous
1
2013
554
0.100
Why?
Orphan Drug Production
1
2012
5
0.100
Why?
Radiography
1
2014
823
0.100
Why?
Forecasting
1
2013
351
0.100
Why?
Long-Term Care
1
2012
70
0.100
Why?
Atherosclerosis
1
2020
923
0.100
Why?
Graft vs Host Disease
1
2016
543
0.090
Why?
Bone Density
1
2014
319
0.090
Why?
Endothelial Cells
2
2013
526
0.090
Why?
Postoperative Period
4
2022
334
0.090
Why?
California
1
2012
128
0.090
Why?
Kidney Glomerulus
2
2024
77
0.090
Why?
Recurrence
3
2016
1420
0.090
Why?
Reoperation
2
2024
833
0.090
Why?
Government Agencies
1
2011
11
0.090
Why?
Netherlands
2
2011
38
0.090
Why?
Geriatric Assessment
1
2012
174
0.090
Why?
Aging
2
2010
1181
0.090
Why?
Reproducibility of Results
4
2023
2891
0.090
Why?
Life Style
1
2014
416
0.090
Why?
Sulfonylurea Compounds
1
2010
17
0.090
Why?
Spironolactone
1
2010
22
0.090
Why?
Mutation
1
2004
5845
0.090
Why?
Stem Cells
2
2013
707
0.090
Why?
Child
12
2022
24421
0.080
Why?
Palliative Care
1
2014
433
0.080
Why?
Clinical Competence
1
2017
1007
0.080
Why?
Primary Prevention
1
2011
172
0.080
Why?
Renal Elimination
2
2019
10
0.080
Why?
Electrocardiography
2
2023
978
0.080
Why?
Dietary Supplements
1
2013
472
0.080
Why?
Psychotropic Drugs
1
2010
122
0.080
Why?
Analgesics
1
2010
127
0.080
Why?
Geography
1
2009
113
0.080
Why?
Sensitivity and Specificity
2
2005
2057
0.080
Why?
Models, Theoretical
1
2011
363
0.080
Why?
Anxiety
2
2022
957
0.080
Why?
Internationality
2
2020
132
0.080
Why?
Lung
1
2016
1496
0.070
Why?
Patient Reported Outcome Measures
2
2021
173
0.070
Why?
Data Interpretation, Statistical
3
2014
233
0.070
Why?
Receptors, Angiotensin
1
2007
21
0.070
Why?
Quality of Health Care
1
2011
392
0.070
Why?
Decision Support Techniques
1
2010
290
0.070
Why?
Stakeholder Participation
2
2018
25
0.070
Why?
Preoperative Care
1
2009
355
0.070
Why?
Hematopoietic Stem Cell Transplantation
1
2016
1203
0.070
Why?
Calcium Phosphates
1
2007
8
0.070
Why?
Lovastatin
1
2007
27
0.070
Why?
Heparin Antagonists
1
2007
5
0.070
Why?
Prolactin
1
2007
114
0.070
Why?
Patient Admission
1
2008
184
0.070
Why?
Simvastatin
1
2007
76
0.070
Why?
Bacteremia
1
2011
406
0.070
Why?
Heptanoic Acids
1
2007
79
0.070
Why?
Clinical Decision-Making
2
2019
264
0.070
Why?
Hypnotics and Sedatives
1
2007
132
0.060
Why?
Isosorbide Dinitrate
1
2005
4
0.060
Why?
Hydralazine
1
2005
8
0.060
Why?
Graft Occlusion, Vascular
1
2006
101
0.060
Why?
Alberta
2
2016
45
0.060
Why?
Interdisciplinary Communication
2
2017
130
0.060
Why?
Indians, North American
2
2018
58
0.060
Why?
Insurance, Pharmaceutical Services
1
2005
10
0.060
Why?
Body Height
1
2007
215
0.060
Why?
Equipment Failure
1
2006
121
0.060
Why?
Insulin
1
2010
1203
0.060
Why?
Hemarthrosis
1
2005
2
0.060
Why?
Diet Surveys
1
2005
98
0.060
Why?
Pyrroles
1
2007
182
0.060
Why?
Pregnancy
2
2015
7207
0.060
Why?
Biopsy
2
2019
1238
0.060
Why?
Demography
1
2006
239
0.060
Why?
Hemophilia A
1
2005
21
0.060
Why?
Erythrocyte Count
1
2004
21
0.060
Why?
Blood Coagulation Factors
1
2005
35
0.060
Why?
Pulmonary Disease, Chronic Obstructive
2
2016
604
0.060
Why?
Child, Preschool
7
2017
14027
0.060
Why?
Prednisolone
2
2004
74
0.060
Why?
Thrombocytopenia
1
2007
226
0.060
Why?
Polyethylenes
1
2004
8
0.060
Why?
Epoxy Compounds
1
2004
18
0.060
Why?
Nursing Homes
1
2005
93
0.060
Why?
Complement Inactivating Agents
1
2024
12
0.060
Why?
Europe
2
2021
354
0.060
Why?
Inflammation
2
2018
1446
0.060
Why?
Arm
1
2024
81
0.060
Why?
Complement System Proteins
1
2024
58
0.060
Why?
Anti-Bacterial Agents
3
2022
2431
0.060
Why?
Chemical and Drug Induced Liver Injury
1
2005
108
0.060
Why?
Orthopedic Procedures
1
2004
69
0.050
Why?
Genetic Markers
1
2005
603
0.050
Why?
Prolyl Hydroxylases
1
2023
3
0.050
Why?
Anticholesteremic Agents
1
2006
235
0.050
Why?
Calcium Channel Agonists
1
2003
11
0.050
Why?
Hypoxia-Inducible Factor-Proline Dioxygenases
1
2023
22
0.050
Why?
Fasting
1
2004
294
0.050
Why?
Long QT Syndrome
1
2024
84
0.050
Why?
Cholesterol
1
2006
541
0.050
Why?
Calcitriol
1
2003
80
0.050
Why?
Endothelium, Vascular
1
2006
527
0.050
Why?
Fluvoxamine
1
2022
25
0.050
Why?
Direct Service Costs
1
2002
8
0.050
Why?
Value of Life
1
2002
9
0.050
Why?
Antifungal Agents
1
2005
291
0.050
Why?
Transferrins
1
2022
2
0.050
Why?
Paroxetine
1
2022
28
0.050
Why?
Peritoneal Dialysis, Continuous Ambulatory
1
2002
21
0.050
Why?
Amoxicillin-Potassium Clavulanate Combination
1
2022
5
0.050
Why?
Fluoxetine
1
2022
43
0.050
Why?
Social Values
1
2002
47
0.050
Why?
Bone Marrow Transplantation
1
2005
575
0.050
Why?
Hepcidins
1
2022
19
0.050
Why?
Technology Assessment, Biomedical
1
2002
32
0.050
Why?
Bradycardia
1
2022
61
0.050
Why?
Clinical Trials, Phase III as Topic
1
2022
69
0.050
Why?
Ischemia
2
2006
363
0.050
Why?
Levofloxacin
1
2022
45
0.050
Why?
Vaginal Smears
1
2002
48
0.050
Why?
Homozygote
1
2004
547
0.050
Why?
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
2022
19
0.050
Why?
Ultrafiltration
1
2021
13
0.050
Why?
Prescriptions
1
2022
40
0.050
Why?
Organ Transplantation
1
2004
168
0.050
Why?
Heterozygote
1
2004
671
0.050
Why?
Bias
1
2002
133
0.050
Why?
Hematopoietic Stem Cells
1
2006
541
0.050
Why?
Mammography
1
2002
114
0.050
Why?
Retreatment
1
2001
89
0.050
Why?
Genetic Predisposition to Disease
2
2018
3157
0.050
Why?
Likelihood Functions
1
2001
114
0.050
Why?
Amoxicillin
1
2022
121
0.050
Why?
Ireland
1
2021
28
0.050
Why?
Smoking
1
2007
1051
0.050
Why?
Prostate-Specific Antigen
1
2002
255
0.050
Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2000
26
0.040
Why?
Pyridoxine
1
2000
14
0.040
Why?
International Agencies
1
2020
29
0.040
Why?
Sodium
1
2022
297
0.040
Why?
Social Class
1
2001
190
0.040
Why?
Antibodies, Monoclonal
1
2006
1033
0.040
Why?
Polymerase Chain Reaction
1
2004
1586
0.040
Why?
Data Collection
1
2022
381
0.040
Why?
Health Facilities, Proprietary
1
2019
3
0.040
Why?
Diabetic Retinopathy
1
2002
155
0.040
Why?
Optic Nerve
1
2001
114
0.040
Why?
Base Sequence
1
2004
3103
0.040
Why?
Health Literacy
1
2020
80
0.040
Why?
Antidepressive Agents
1
2022
293
0.040
Why?
Review Literature as Topic
1
2019
43
0.040
Why?
Gene Expression
1
2004
1560
0.040
Why?
Survival
1
2019
19
0.040
Why?
Datasets as Topic
1
2019
89
0.040
Why?
Environmental Exposure
1
2021
220
0.040
Why?
Diagnostic Self Evaluation
1
2019
21
0.040
Why?
Paraproteinemias
1
2019
16
0.040
Why?
Health Promotion
1
2002
389
0.040
Why?
Medical Oncology
1
2020
216
0.040
Why?
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
1
2019
21
0.040
Why?
Molecular Sequence Data
1
2004
3892
0.040
Why?
Aorta
1
2022
552
0.040
Why?
Growth
1
2019
106
0.040
Why?
Cadaver
2
2011
132
0.040
Why?
Anti-Inflammatory Agents
1
2001
293
0.040
Why?
Mental Disorders
1
2005
828
0.040
Why?
Podocytes
1
2019
73
0.040
Why?
Health Facilities
1
2018
61
0.040
Why?
Urea
1
2019
231
0.040
Why?
Cluster Analysis
1
2019
398
0.040
Why?
Hospital Costs
1
2019
180
0.040
Why?
Contraindications, Drug
1
2017
3
0.040
Why?
Erythrocyte Transfusion
1
2019
130
0.040
Why?
Mitral Valve
1
2019
250
0.040
Why?
Health Care Surveys
1
2018
285
0.040
Why?
Glucose
1
2022
877
0.030
Why?
Seasons
1
2019
312
0.030
Why?
Monte Carlo Method
1
2017
94
0.030
Why?
Hospitals
1
2019
390
0.030
Why?
Reference Values
1
2018
718
0.030
Why?
Stroke Volume
1
2019
490
0.030
Why?
Lipids
1
2020
523
0.030
Why?
Parent-Child Relations
1
2018
248
0.030
Why?
Histocompatibility
1
2015
47
0.030
Why?
Blood Vessel Prosthesis
2
2015
546
0.030
Why?
National Institutes of Health (U.S.)
1
2016
133
0.030
Why?
Genetic Association Studies
1
2019
779
0.030
Why?
Host-Pathogen Interactions
1
2018
253
0.030
Why?
Choice Behavior
1
2016
132
0.030
Why?
Respiratory Function Tests
1
2016
199
0.030
Why?
Hydroxychloroquine
1
2015
17
0.030
Why?
Culture
1
2015
67
0.030
Why?
Cost Control
1
2015
24
0.030
Why?
Cooperative Behavior
1
2016
218
0.030
Why?
Anti-HIV Agents
1
2018
320
0.030
Why?
Health Priorities
1
2015
36
0.030
Why?
Waist Circumference
1
2014
89
0.030
Why?
Disease-Free Survival
1
2016
897
0.030
Why?
Disease Management
1
2018
528
0.030
Why?
Self Report
1
2017
517
0.030
Why?
Prosthesis Design
1
2017
681
0.030
Why?
Progestins
1
2014
48
0.030
Why?
Inventions
1
2013
17
0.030
Why?
Antirheumatic Agents
1
2015
121
0.030
Why?
Oxidative Stress
1
2018
837
0.030
Why?
Matched-Pair Analysis
1
2012
28
0.030
Why?
Cell Count
1
2013
254
0.030
Why?
Anti-Arrhythmia Agents
1
2014
224
0.030
Why?
Reticulocytes
1
2012
43
0.030
Why?
Glucocorticoids
1
2015
383
0.020
Why?
Preoperative Period
1
2012
88
0.020
Why?
Diagnosis, Differential
1
2018
1897
0.020
Why?
Texas
1
2021
3588
0.020
Why?
Health Services Needs and Demand
1
2013
175
0.020
Why?
Infant
3
2016
12516
0.020
Why?
Lidocaine
1
2012
46
0.020
Why?
Neuralgia
1
2012
44
0.020
Why?
Heart Transplantation
1
2018
862
0.020
Why?
Equipment Design
1
2013
599
0.020
Why?
Hormone Replacement Therapy
1
2014
196
0.020
Why?
Benzhydryl Compounds
1
2012
66
0.020
Why?
Familial Primary Pulmonary Hypertension
1
2011
20
0.020
Why?
Estrogens
1
2014
504
0.020
Why?
Intention to Treat Analysis
1
2011
66
0.020
Why?
Surgical Procedures, Operative
1
2012
184
0.020
Why?
Organization and Administration
1
2010
4
0.020
Why?
Infant, Newborn
2
2016
8233
0.020
Why?
Least-Squares Analysis
1
2009
32
0.020
Why?
Age of Onset
1
2011
595
0.020
Why?
Drug Evaluation
1
2009
107
0.020
Why?
Software
1
2014
684
0.020
Why?
Pediatrics
1
2018
1152
0.020
Why?
Educational Status
1
2008
276
0.020
Why?
Decision Trees
1
2007
50
0.020
Why?
Logical Observation Identifiers Names and Codes
1
2006
1
0.020
Why?
Hospital Records
1
2006
8
0.020
Why?
Forms and Records Control
1
2006
10
0.020
Why?
Dose-Response Relationship, Immunologic
1
2006
108
0.020
Why?
Antilymphocyte Serum
1
2006
56
0.020
Why?
Lymphocyte Count
1
2006
118
0.020
Why?
Lymphocyte Depletion
1
2006
123
0.020
Why?
Phosphatidylglycerols
1
2005
6
0.020
Why?
Deoxycholic Acid
1
2005
13
0.020
Why?
Factor VII
1
2005
15
0.020
Why?
Phosphatidylcholines
1
2005
37
0.020
Why?
Probability
1
2006
320
0.020
Why?
Medical Records
1
2006
192
0.020
Why?
Factor VIIa
1
2005
24
0.020
Why?
Fluconazole
1
2005
47
0.010
Why?
T-Lymphocyte Subsets
1
2006
199
0.010
Why?
Models, Economic
1
2005
51
0.010
Why?
Amphotericin B
1
2005
90
0.010
Why?
Factor VIII
1
2005
45
0.010
Why?
Cell Culture Techniques
1
2006
281
0.010
Why?
Home Care Services
1
2005
73
0.010
Why?
Drug Combinations
1
2005
267
0.010
Why?
Health Maintenance Organizations
1
2004
22
0.010
Why?
Antigens, CD
1
2006
432
0.010
Why?
Uric Acid
1
2004
95
0.010
Why?
Postoperative Care
1
2006
301
0.010
Why?
Triglycerides
1
2006
575
0.010
Why?
Autoantibodies
1
2005
435
0.010
Why?
Critical Care
1
2007
657
0.010
Why?
Animals
1
2000
34232
0.010
Why?
WINKELMAYER's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (822)
Explore
_
Co-Authors (36)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_